Mark E. Arnold
Bristol-Myers Squibb (United States), IBC Pharmaceuticals (India)
Papers
4
Total Citations
47
H-Index
3
About
Mark E. Arnold is a bioanalytical scientist whose research has centered on laboratory automation, robotic sample preparation, and regulated bioanalysis, with a particular focus on improving the efficiency and reliability of pharmaceutical drug analysis workflows. His most significant contributions involve the development of innovative automation solutions that address longstanding bottlenecks in biological sample processing. Notably, Arnold and colleagues designed a Microsoft Excel-based robotic sample preparation program for fully automated biological sample pipetting and dilution, streamlining a historically rate-limiting step in bioanalytical workflows — a contribution that has garnered 23 citations. His work on automated dried blood spot (DBS) standard and quality control sample preparation using robotic liquid handlers (15 citations) has been particularly impactful, reducing the labor-intensive manual processes inherent to DBS bioanalysis. Arnold also contributed to advancing simplified, evaporation-free solid phase extraction workflows compatible with LC–MS/MS regulated bioanalysis. His career spans decades of engagement with laboratory automation, as evidenced by his participation in the 1991 International Symposium on Laboratory Automation and Robotics. Collectively, his work has meaningfully advanced reproducibility, throughput, and regulatory compliance in pharmaceutical bioanalytical laboratories.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4The 1991 International Symposium on Laboratory Automation and Robotics2 citations · 1991